What are the treatment options for migraine headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Migraine Headaches

Start with combination therapy of an NSAID plus acetaminophen for mild to moderate migraine, and escalate to a triptan combined with an NSAID or acetaminophen for moderate to severe attacks or when first-line therapy fails. 1

First-Line Treatment Algorithm

For Mild to Moderate Migraine

  • Begin with NSAIDs (ibuprofen 400-800 mg, naproxen 500-1000 mg, or aspirin 900-1000 mg) or the combination of acetaminophen 1000 mg + aspirin 900 mg + caffeine 130 mg 1, 2
  • Acetaminophen 1000 mg can be used as monotherapy but is less effective than NSAIDs or combination therapy 2
  • Ibuprofen 400 mg provides 2-hour headache relief in 57% of patients versus 25% with placebo (NNT 3.2), with 2-hour pain-free rates of 26% versus 12% (NNT 7.2) 3
  • Initiate treatment as early as possible during the attack—early administration significantly improves efficacy 1, 2

For Moderate to Severe Migraine

  • Add a triptan to an NSAID, or to acetaminophen when NSAIDs are contraindicated 1
  • Triptans are first-line therapy for moderate to severe attacks, with oral options including sumatriptan 50-100 mg, rizatriptan 10 mg, eletriptan 40-80 mg, almotriptan 12.5 mg, naratriptan 2.5 mg, frovatriptan 2.5 mg, or zolmitriptan 2.5-5 mg 1, 4
  • Sumatriptan 100 mg provides 2-hour headache relief in 62% of patients versus 27% with placebo, with 4-hour relief in 79% versus 38% 5
  • Combination therapy of triptan plus NSAID prevents the 40% recurrence rate within 48 hours seen with triptan monotherapy 6

Route of Administration Considerations

  • Use non-oral triptans (subcutaneous sumatriptan 6 mg or intranasal formulations) plus an antiemetic for patients with severe nausea or vomiting 1, 6
  • Subcutaneous sumatriptan 6 mg provides the highest efficacy with 59% achieving complete pain relief by 2 hours, though with higher adverse event rates 6
  • Intranasal sumatriptan (5-20 mg) or zolmitriptan are particularly useful when significant nausea or vomiting is present 6, 7

Second-Line and Rescue Therapy

When Combination Triptan + NSAID Therapy Fails

  • Escalate to CGRP antagonists (gepants: rimegepant 75 mg, ubrogepant 50-100 mg, or zavegepant 10 mg nasal spray) or dihydroergotamine 1, 2
  • Consider lasmiditan 50-100 mg only after failure of all other pharmacologic treatments included in this guideline 1, 2

For Severe Attacks Requiring Parenteral Therapy

  • IV ketorolac 30 mg plus IV metoclopramide 10 mg is first-line combination therapy for severe migraine in emergency or urgent care settings 2, 6
  • IV prochlorperazine 10 mg is comparable to metoclopramide in efficacy and can be used as an alternative 6
  • IV dihydroergotamine is an effective option for refractory cases 1, 4

Critical Medications to Avoid

  • Do not use opioids or butalbital-containing compounds for acute episodic migraine treatment 1, 2
  • These medications lead to dependency, rebound headaches, medication-overuse headache, and eventual loss of efficacy 2, 6

Medication-Overuse Headache Prevention

  • Limit acute medication use to ≤10 days per month for triptans and ≤15 days per month for NSAIDs 1, 2
  • Medication overuse headache is defined as headache occurring on ≥15 days per month for at least 3 months in patients with a preexisting headache disorder that develops due to overuse of acute medication 1
  • Initiate preventive therapy if acute treatment is needed more than 2 days per week 2, 6

Treatment Failure Algorithm

When Current Medication Stops Working

  • First, try a different triptan—failure of one triptan does not predict failure of others 6
  • Ensure early administration during the attack while headache is still mild, as triptans are most effective when taken early 6
  • Consider route change (e.g., subcutaneous sumatriptan if oral fails), particularly for patients who rapidly reach peak intensity or have vomiting 6
  • Rule out medication-overuse headache if using acute medications more than twice weekly 6

Transition to Preventive Therapy

  • If headaches continue to impair quality of life despite optimized acute therapy, or if acute medications are used more than 2 days per week, preventive therapy is indicated 2, 6
  • Preventive therapy reduces attack frequency and can restore responsiveness to acute treatments 6
  • Do not allow patients to increase frequency of acute medication use in response to treatment failure—this creates a vicious cycle of medication-overuse headache 6

Special Populations

Pregnancy and Lactation

  • Acetaminophen is first-line treatment for pregnant or breastfeeding patients 2
  • NSAIDs can be used prior to the third trimester 2, 7
  • Discuss adverse effects of pharmacologic treatments during pregnancy and lactation with all patients of childbearing potential 1

Pediatric Patients

  • Acetaminophen, ibuprofen, intranasal sumatriptan, and intranasal zolmitriptan appear effective in children and adolescents, though data are limited 7

Essential Lifestyle Modifications

  • Counsel all patients on lifestyle modifications including adequate hydration, regular meals, consistent sleep schedule, regular aerobic exercise, stress management techniques, and weight loss if overweight 2

Cost Considerations

  • Prescribe less costly recommended medications when equally effective options exist—generic NSAIDs and older triptans (sumatriptan, naratriptan) are significantly less expensive than newer agents 2
  • Over-the-counter medications (acetaminophen, ibuprofen, naproxen, aspirin) have lower cost, fewer adverse effects, and more favorable routes of administration compared with prescription medications 8

Common Pitfalls to Avoid

  • Do not delay treatment—early administration is critical for efficacy 1, 2
  • Do not assume all triptans are equivalent for an individual patient—response varies and switching within the class is appropriate 1, 6
  • Do not restrict antiemetics only to patients who are vomiting—nausea itself is one of the most disabling symptoms and warrants treatment 6
  • Do not establish patterns of frequent opioid use, as this leads to medication-overuse headache and dependency 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ibuprofen with or without an antiemetic for acute migraine headaches in adults.

The Cochrane database of systematic reviews, 2010

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of acute migraine headache.

American family physician, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.